Guidance on drug establishment licences. : H14-311/2020E-PDF
"This guide is for companies in the drug manufacturing industry. It will help to facilitate understanding and compliance with Part C, Division 1A of the Food and Drug Regulations (FDR with regards to drug establishment licence (DEL) requirements"--Purpose, page 6.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.884429&sl=1
Ministère/Organisme | Canada. Health Canada, issuing body. |
---|---|
Titre | Guidance on drug establishment licences. |
Variante du titre | Guidance on drug establishment licences, version 8 (GUI-0002) |
Type de publication | Monographie |
Langue | [Anglais] |
Autres langues publiées | [Français] |
Édition précédente | Guidance on drug establishment licences and associated fees. |
Format | Électronique |
Document électronique | |
Note(s) | Issued also in French under title: Document d'orientation sur les licences d'établissement de produits pharmaceutiques. "GUI-0002." "April 1, 2020." "Pub.: 190596." Issued also in HTML format. Includes bibliographical references (pages 42-45). |
Information sur la publication | Ottawa, ON : Health Canada = Santé Canada, 2020. ©2020 |
Description | 1 online resource (45 pages) |
ISBN | 9780660339962 |
Numéro de catalogue |
|
Descripteurs | Pharmaceutical industry -- Licenses -- Canada. Pharmaceutical industry -- Safety regulations -- Canada. Pharmaceutical policy -- Canada. |